SATO VICKI L 4
4 · Denali Therapeutics Inc. · Filed Nov 12, 2024
Insider Transaction Report
Form 4
SATO VICKI L
Director
Transactions
- Sale
Common Stock
2024-11-07$30.00/sh−1,020$30,600→ 111,056 total
Footnotes (2)
- [F1]The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted March 21, 2024.
- [F2]Includes 5,967 unvested RSUs.